In this context, HER2-positive BC refers to tumors with high levels of HER2 protein expression, as assessed by immunohistochemistry (IHC), and/or HER2 amplification, as assessed by in situ hybridization (ISH) [2]. This evidence concerns the gene ERBB2 and breast cancer.